Transcatheter Aortic Valve Implantation (TAVI) Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Transcatheter aortic valve implantation is a procedure that replace your disease aortic valve with manmade valve. The aortic valve control blood from your heart to the body. If the valve becomes stiff then person have a condition called aortic stenosis. In these condition patient suffering from irregular heart bit, chest pain, dizziness, abnormal heart sound etc. transcatheter aortic valve implantation (TAVI) also known as transcatheter aortic valve replacement (TAVR). These procedure mainly used to patient who were weak to undergo open heart surgery.

MARKET DYNAMICS

The transcatheter aortic valve implantation market is expected to grow during the forecast period owing to the key driving factors such as rising geriatric population, increase incidence of cardiovascular disease, raising in adoption rates of TANVI devices in the market, awareness related to transcatheter aortic valve implantation treatment, raising life expectancy and others. In addition, various players in the emerging market have strong pipeline product and high potential which are anticipated to create immense growth opportunities for the market during the forecast period.

MARKET SCOPE

The "Global Transcatheter Aortic Valve Implantation Market Analysis to 2031" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of transcatheter aortic valve implantation with detailed market segmentation by procedure, end user and geography. The global transcatheter aortic valve implantation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading the transcatheter aortic valve implantation market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global transcatheter aortic valve implantation market is segmented on the basis of procedure end user and therapy. Based on procedure, the market is segmented as transfemoral implantation, transapical implantation and transaortic implantation. On the basis of end user, the transcatheter aortic valve implantation market is classify into hospitals, cardiac center and ambulatory surgical center.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global transcatheter aortic valve implantation market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The transcatheter aortic valve implantation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting transcatheter aortic valve implantation market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the transcatheter aortic valve implantation market in these regions.

MARKET PLAYERS

The reports cover key developments in the transcatheter aortic valve implantation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from transcatheter aortic valve implantation market are anticipated to lucrative growth opportunities in the future with the rising demand for transcatheter aortic valve implantation market in the global market. Below mentioned is the list of few companies engaged in the transcatheter aortic valve implantation market.

The report also includes the profiles of key transcatheter aortic valve implantation market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Abbott
• Medtronic
• Boston Scientific Corporation
• Meril Life Sciences Pvt. Ltd
• Edwards Lifesciences Corporation
• JenaValve Technology, Inc
• VENUS MEDTECH
• NVT AG
• HLT
• Transcatheter Technologies GmbH

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Transcatheter Aortic Valve Implantation (TAVI) Report Scope